Obsidio™ Conformable Embolic Registry
Completed · NCT06170619
Conditions: Hypervascular Tumors, Bleeding, Hemorrhage
At a glance
- Research payments reported, 2025
- $621,856
- U.S. investigators named
- 20
- Sites paid
- 20
- Planned or actual enrollment
- 125
About the trial
- Sponsor
- Boston Scientific Corporation
- Tested
- Obsidio™ Conformable Embolic (device)
- Dates
- Started 2024-06-19; completion 2025-09-09
- Results posted
- Not yet
OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio.
From ClinicalTrials.gov, last updated 2026-06-01. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Boston Scientific Corporation reported $621,856 in research payments for this study in 2025 (130 payments).
Products named: Clinical Trial Product
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Merve Ozen, MD Interventional Radiology · Scottsdale, AZ
- Zachary M. Haber, MD Radiology · Los Angeles, CA
- Pavan Khanna, M.D. Radiology · Stockton, CA
- Christopher J. Grilli, D.O. Interventional Radiology · Newark, DE
- Abhishek Kumar, M.D. Neurology · Newark, DE
- Kirema I. Garcia-reyes, MD Interventional Radiology · Atlanta, GA
- Nima Kokabi, MD Interventional Radiology · Atlanta, GA
- Peter J. Park, M.D. Interventional Radiology · Atlanta, GA
- Andrew C. Gordon, MD, PHD Interventional Radiology · Chicago, IL
- Abdul S. Khan, MD Interventional Radiology · Chicago, IL
- Ian T. Kozlowski, MD Interventional Radiology · Overland Park, KS
- Muneeb Ahmed, M.D. Interventional Radiology · Boston, MA
- Vincent Wu, M.D. Radiology · Boston, MA
- Nariman Nezami, MD Interventional Radiology · Baltimore, MD
- Kevin Henseler, M.D. Radiology · Roseville, MN
- Alexander Ushinsky, MD Radiology · Saint Louis, MO
- Gary Siskin Interventional Radiology · Albany, NY
- Ahmed M. Abdel Aal, MD, PHD Radiology · Houston, TX
- Ketan Y. Shah, M.D. Interventional Radiology · Houston, TX
- Guy E. Johnson Radiology · Seattle, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Ut MD Anderson Cancer Center $109,249
- University of North Carolina at Chapel Hill $45,023
- Rutgers the State University $44,254
- The University of Texas Health Science Center at Houston $42,484
- Georgetown University $41,168
- Washington University $36,586
- University of Washington Medical Ctr, WA $32,219
- Ronald Reagan UCLA Medical Center, CA $31,550
- Massachusetts General Hospital, MA $29,937
- Community Care Physicians PLLC $27,176
- Northwestern University $25,818
- Emory University Hospital, GA $24,526
- Mayo Clinic Hospital, AZ $24,368
- St Josephs Hospital and Medical Center, AZ $22,913
- University of Chicago $19,670
- Icahn School of Medicine at Mount Sinai $18,599
- Christiana Hospital, DE $18,267
- The Childrens Heart Clinic P A $13,602
- Beth Israel Deaconess Medical Center, MA $11,037
- University of Kansas Medical Center Research Institute Inc $3,414
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.